# Italian Platelet Technology Assessment Study

> **NCT01642563** · PHASE3 · TERMINATED · sponsor: **Centro Nazionale Sangue** · enrollment: 456 (actual)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **PROCEDURE:** Platelet transfusion
- **PROCEDURE:** Platelet transfusion

## Key facts

- **NCT ID:** NCT01642563
- **Lead sponsor:** Centro Nazionale Sangue
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2014-10
- **Final completion:** 2015-03
- **Target enrollment:** 456 (ACTUAL)
- **Why stopped:** Patient enrolment below planned schedule
- **Last updated:** 2015-07-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01642563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01642563, "Italian Platelet Technology Assessment Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01642563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*